Evolution of Hepatitis B Serological Markers in HIV-Infected Patients Receiving Highly Active Antiretroviral TherapyWang‐Huei Sheng, Shan‐Chwen Chang, Jia‐Horng Kao et al.|Clinical Infectious Diseases|2007Cited by 87
Impact of Hepatitis D Virus Infection on the Long-Term Outcomes of Patients with Hepatitis B Virus and HIV Coinfection in the Era of Highly Active Antiretroviral Therapy: A Matched Cohort StudyWang‐Huei Sheng, Shan‐Chwen Chang, Jia‐Horng Kao et al.|Clinical Infectious Diseases|2007Cited by 84
Risk of Recurrent Nontyphoid Salmonella Bacteremia in HIV-Infected Patients in the Era of Highly Active Antiretroviral Therapy and an Increasing Trend of Fluoroquinolone ResistanceChien‐Ching Hung, Shan‐Chwen Chang, Meng-Yu Hung et al.|Clinical Infectious Diseases|2007Cited by 58
Reconstituted Immunity against Persistent Parvovirus B19 Infection in a Patient with Acquired Immunodeficiency Syndrome after Highly Active Antiretroviral TherapyM.-Y. Chen, Szu‐Min Hsieh, Chien‐Ching Hung et al.|Clinical Infectious Diseases|2001Cited by 41
Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in TaiwanSui‐Yuan Chang, Shan‐Chwen Chang, M.-Y. Chen et al.|Journal of Antimicrobial Chemotherapy|2008Cited by 32